ORIGINAL RESEARCH article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1556364
Distribution characteristics of aerosol microorganisms in bronchoscopy room and the risk assessment of nosocomial infection
Provisionally accepted- Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: A large number of aerosols containing pathogenic microorganisms can be produced during bronchoscopy. The aim of the study is to evaluate the risk of nosocomial infection by pathogenic microorganisms after bronchoscopy. The distribution characteristics of aerosol microorganisms were detected before and after bronchoscopy, and then compared with the distribution characteristics of the patients' respiratory pathogens.Methods: A total of 152 patients underwent bronchoscopy in the bronchoscopy room from May 06, 2024 to June 30, 2024. Airborne microorganisms were collected in the bronchoscopy room before and after the bronchoscopy, then cultured, counted and identified, to analyze the species, numbers and changes of microorganisms. At the same time, the data of respiratory pathogens and nosocomial infection of all patients were collected to evaluate the correlation between air microorganisms and respiratory pathogens, and the risk of nosocomial infection.Results: 1. The concentration of air microorganisms after bronchoscopy was 89.60±63.52 CFU/m 3 , significantly higher than 43.80±26.70 CFU/m 3 before bronchoscopy (P < 0.001). The increase in air microorganism concentration was in accordance with the total number of patients and the number of patients with respiratory infectious diseases on the same day (P < 0.001). After bronchoscopy for patients with infectious diseases, the concentration was significantly higher than that for patients with non-infectious diseases (P < 0.05). 2. The bacteria accounted for 75.34%, 70.35% of the total aerosol microorganisms, fungi 22.17%, 26.80% before and after bronchoscopy. The bacteria mainly includedNeisseria faunalis, Staphylococcus capitis, etc. The fungi mainly included Aspergillus flavus, Aspergillus niger, Saccharomyces albicans, Penicillium spp., etc. 3. The increase in air microorganisms after bronchoscopy was consistent with the distribution of pathogens causing respiratory infections in patients (P < 0.001). The increased pathogens were mainly composed of common respiratory pathogens, but it did not increase the risk of nosocomial respiratory infections in patients (P = 0.735).Bronchoscopy can increase the concentration of aerosol microorganisms. The increased microorganisms are related to the respiratory pathogens of patients, which are mainly the common pathogens of pulmonary infection. This, however, does not increase the risk of nosocomial respiratory infection.
Keywords: Bronchoscopy, aerosol, microorganisms, respiratory pathogens, Nosocomial infection
Received: 06 Jan 2025; Accepted: 15 Apr 2025.
Copyright: © 2025 Zhu, Xu, Chen and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Minhua Shi, Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.